PND68 - COST-EFFECTIVENESS OF TERIFLUNOMIDE COMPARED TO INTERFERON BETA-1B FOR RELAPSING MULTIPLE SCLEROSIS PATIENTS IN CHINA
Oct 1, 2018, 00:00 AM
10.1016/j.jval.2018.09.2034
https://www.valueinhealthjournal.com/article/S1098-3015(18)35336-1/fulltext
Section Title :
Section Order :
1391
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35336-1&doi=10.1016/j.jval.2018.09.2034